Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo.
about
Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and diseaseRole of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and CancerXenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin modelsCoal tar induces AHR-dependent skin barrier repair in atopic dermatitisTranscriptional changes in organoculture of full-thickness human skin following topical application of all-trans retinoic acid.Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease.Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiationOld King coal - molecular mechanisms underlying an ancient treatment for atopic eczemaMolecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo.Diclofenac delays micropore closure following microneedle treatment in human subjectsFactors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.Induction of cytochrome P450 enzymes: a view on human in vivo findings.Pterostilbene: Biomedical applications.Pharmacogenetics of topical and systemic treatment of psoriasis.Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters.Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models
P2860
Q23919671-D769F966-3C76-4BA3-8B59-93653BFC3B1CQ26800202-DB2DF2B5-4B8B-4FAA-BBEF-AD4D3393D33FQ26825940-2CE8E19E-5940-4D7F-B4D7-D94818D3C1C3Q34324282-05577989-079E-4DD1-8832-5DE664F49B68Q34693605-F606AE2B-A4A3-4CAD-B0E7-2A5F54EC51E0Q35106239-0CB2611B-C75A-429A-8317-EBA324BB1485Q36141531-DB81913E-A0EE-45D4-8717-51198FED9766Q36580486-CC58AD0B-1B80-4F6E-9091-E6284257F22BQ36609453-A951FD2E-B12B-41B2-BFB4-DF704A147DB2Q37051274-F80B6468-1E30-4F28-99DB-6A6712293A82Q37874681-A7B5D0C2-8D7B-4A5B-98C1-042D51A26ACCQ38057372-F96A93B1-FDE6-42AB-9488-88C835EAF21CQ38117659-CCE5ABE5-BCB8-48B0-9CC1-B16261FDE20FQ38148599-C664B331-FF02-452A-9CF7-BACD6BD14140Q48040414-6DA2C0E1-D757-43A4-9522-110BE4A44666Q57095660-855954FF-D9DC-4F35-A098-CB6FAEB9BC3C
P2860
Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Regulation of cutaneous drug-m ...... l drugs in human skin in vivo.
@en
Regulation of cutaneous drug-m ...... l drugs in human skin in vivo.
@nl
type
label
Regulation of cutaneous drug-m ...... l drugs in human skin in vivo.
@en
Regulation of cutaneous drug-m ...... l drugs in human skin in vivo.
@nl
prefLabel
Regulation of cutaneous drug-m ...... l drugs in human skin in vivo.
@en
Regulation of cutaneous drug-m ...... l drugs in human skin in vivo.
@nl
P2093
P2860
P50
P1476
Regulation of cutaneous drug-m ...... al drugs in human skin in vivo
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2006.07317.X
P407
P577
2006-08-01T00:00:00Z